Etodolac (Lodine) Manufacturing Plant Project Report 2025

The report is the result of extensive primary and secondary research, offering a detailed analysis of current market trends. It profiles key industry players, giving insights into their market strategies, production capacities, and financial performance, which are crucial for benchmarking and competitive analysis.

It delves into historical, current, and forecasted price trends, helping stakeholders understand market dynamics and price volatility. The report provides a thorough analysis of the mass balance and raw materials requirements, ensuring a clear understanding of the input-output ratios essential for efficient production. Detailed examinations of the various unit operations integral to the etodolac (Lodine) manufacturing process are included, highlighting process optimisation techniques and technological advancements.

The report presents a comprehensive capital cost analysis, detailing the financial investment required for setting up an etodolac (Lodine) plant. This includes an exhaustive breakdown of costs associated with raw materials, catchem, utilities, labour, packaging, transportation, land acquisition, construction, and machinery. Additionally, it offers an in-depth look at the operating costs, providing clarity on the recurring expenses involved in running the plant.

Projected profit margins and optimal product pricing strategies are outlined, offering guidance on maximising profitability. The report also addresses regulatory frameworks, environmental impacts, and sustainability measures pertinent to the etodolac (Lodine) industry.

About Etodolac (Lodine)

Etodolac (Lodine) is a nonsteroidal anti-inflammatory drug (NSAID) used to treat osteoarthritis, rheumatoid arthritis, and acute pain. It works by inhibiting the production of prostaglandins, which are substances that promote inflammation and pain. Commonly prescribed dosages include 300 mg and 400 mg, taken either once or twice daily, depending on the severity of the condition. Etodolac was patented in 1971 and approved for medical use in 1985. It has since been manufactured by various pharmaceutical companies, including Forest Laboratories and Teva Pharmaceuticals, under different brand names, with generic etodolac also available.

Properties of Etodolac (Lodine)

Etodolac exhibits analgesic (pain-relieving) and antipyretic (fever-reducing) properties by inhibiting the synthesis of prostaglandins, which play a crucial role in inflammation and pain perception. Etodolac is a white crystalline solid with a molecular formula of C₁₇H₂₁NO₃ and a molecular weight of 287.35 g/mol. It has a melting point range of 145-148 °C and is insoluble in water but soluble in alcohols and chloroform. 

Manufacturing Process of Etodolac (Lodine)

The production process of etodolac (Lodine) begins with the preparation of raw materials, which involves sourcing the necessary chemical precursors. The synthesis of etodolac includes several steps, starting with the formation of the pyranocarboxylic acid structure, followed by racemisation to obtain a racemic mixture of etodolac. After synthesis, the compound undergoes purification through crystallisation and filtration to isolate pure etodolac. Next, the purified etodolac is formulated by mixing it with excipients such as fillers and binders. The formulation is then processed into tablets or capsules through compression or encapsulation. Quality control is a critical step, where the product is tested for potency, purity, and consistency. Finally, the finished product is packaged for distribution, ensuring that it meets the required standards for safety and efficacy.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Synthesis of Etodolac (Lodine)

The production of etodolac involves several key steps, such as:

Raw Materials:

• Indole (C₈H₇N)

• Ethyl acetoacetate (C₆H₁₀O₃)

• Sodium ethoxide (C₂H₅ONa)

• Ethyl iodide (C₂H₅I)

• Hydrochloric acid (HCl)

• Sodium hydroxide (NaOH)

• Acetic anhydride (C₄H₆O₃)

• Pyridine (C₅H₅N)

Process Description:

Step 1: Alkylation of Indole

Indole is first alkylated with ethyl iodide in the presence of sodium ethoxide to form 1-ethylindole.

C₈H₇N + C₂H₅I + C₂H₅ONa → C₁₀H₁₁N + NaI + C₂H₅OH

Indole + Ethyl iodide + Sodium ethoxide → 1-Ethylindole + Sodium iodide + Ethanol

Step 2: Condensation with Ethyl Acetoacetate

1-Ethylindole is then condensed with ethyl acetoacetate in the presence of sodium ethoxide to form an intermediate product.

C₁₀H₁₁N + C₆H₁₀O₃ + C₂H₅ONa → Intermediate + C₂H₅OH + NaOH

1-Ethylindole + Ethyl acetoacetate + Sodium ethoxide → Intermediate + Ethanol + Sodium hydroxide

Step 3: Cyclisation

The intermediate product undergoes cyclisation to form the core structure of etodolac.

Intermediate → Cyclised Intermediate

Step 4: Acetylation

The cyclised intermediate is then acetylated using acetic anhydride in the presence of pyridine to form etodolac.

Cyclised Intermediate + C₄H₆O₃ → Etodolac (C₁₇H₂₁NO₃) + C₂H₄O₂

Cyclised Intermediate + Acetic anhydride → Etodolac + Acetic acid

Step 5: Purification

The crude etodolac is purified through recrystallisation to obtain the final product in pure form.

Etodolac (crude) → Etodolac (pure)

Applications and Drivers of Etodolac (Lodine)

Lodine is mainly used to treat osteoarthritis and rheumatoid arthritis by reducing inflammation and pain. Etodolac is also approved for treating short-term pain and juvenile rheumatoid arthritis. The extended-release form of etodolac is used to manage acute pain, while the immediate-release form is used for long-term joint pain and inflammation in various types of arthritis. These applications make etodolac an important medication for managing arthritis-related symptoms and improving patients' quality of life, driving its demand.

Key Features of the Etodolac (Lodine) Production Cost Report:

This production cost analysis report by Expert Market Research scrutinises the etodolac (Lodine) manufacturing process, offering a comprehensive overview necessary for stakeholders considering venturing into this sector. Based on the latest economic data, the report encompasses detailed insights into the primary process flow, raw material requirements, reactions involved, utility costs, operating costs, capital investments, pricing strategies, and profit margins. This report is an indispensable resource for entrepreneurs, investors, researchers, consultants, business strategists, and all those who have any kind of stake in the etodolac (Lodine) industry. It equips them with essential information and strategic insights to effectively navigate the complexities of the market.

The following sections detail the comprehensive scope of the prefeasibility report for an etodolac (Lodine) production plant:

• Market Dynamics and Trends: This section analyses the prevailing market conditions, growth drivers, and trends impacting the etodolac (Lodine) industry. It offers a thorough examination of demand fluctuations and projections.

• Geographic Analysis: Detailed insights into the major regions active in etodolac (Lodine) production and consumption, highlighting regional market specifics and growth potential.

• Key Industry Players: Profiles of leading manufacturers in the etodolac (Lodine) sector, outlining their market share, strategic positions, and operational strengths.

• Price Fluctuations: Analysis of historical, current, and projected price trends, providing stakeholders with essential pricing intelligence.

• Technical Specifications and Process Description: A detailed overview of the etodolac (Lodine) production process including the technology used and innovations within the industry.

• Raw Material Requirements and Sourcing: Evaluation of necessary raw materials, their sourcing strategies, and cost implications.

• Utility Requirements and Costs: Detailed analysis of utilities needed to produce etodolac (Lodine), such as electricity, steam, and process water along with their cost assessments. 

• Labour Force Dynamics: Insights into manpower requirements, including skill specifications and labour cost projections.

• Packaging Needs: Overview of packaging requirements for etodolac (Lodine) to ensure product integrity and cost efficiency.

• Logistics and Transportation: Examination of transportation needs and logistics planning for distribution and supply chain efficiency.

• Capital and Operating Costs: An in-depth look at investment requirements, including land acquisition and its development cost, civil work costs, construction, machinery procurement, and ongoing operational expenses, such as salaries and wages, plant overheads, tax and insurance as well as packaging, transportation, and administration costs.

• Financial Performance and Profitability Analysis: Projected profit margins and return on investment based on current market and operational parameters.

• Product Pricing Strategy: Recommendations on pricing mechanisms based on industry benchmarks and production costs.

• Environmental Impact and Regulatory Compliance: Analysis of environmental considerations and compliance with local and international regulations.

• Risk Assessment and Mitigation Strategies: Identification of potential risks associated with etodolac (Lodine) production and strategies to mitigate them.

Key Questions Addressed:

• What are the detailed unit operations for etodolac (Lodine) production?

• Who are major technology licensors with their process evaluation?

• How are raw materials or catchem procured and what are their cost implications?

• What utilities are essential for production and what will they cost?

• What are the labour requirements and how does this affect operational costs?

• What packaging solutions are optimal for cost and efficiency?

• What logistical arrangements are necessary for efficient product distribution?

• What are the estimated land and construction costs for a new etodolac (Lodine) plant?

• How can profitability be maximised in the etodolac (Lodine) market?

• What pricing strategy should be adopted for etodolac (Lodine) to remain competitive?

This prefeasibility report aims to equip potential investors and existing manufacturers with crucial insights to make informed decisions in the etodolac (Lodine) industry.